Core Viewpoint - Zhejiang Huakang Pharmaceutical Co., Ltd. plans to distribute a cash dividend of 2 yuan (including tax) for every 10 shares to all shareholders, with total share capital as of August 20, 2025, being considered for adjustments based on changes in share capital due to convertible bonds, share buybacks, or other factors [1]. Company Overview - The company is listed on the Shanghai Stock Exchange under the stock code 605077, with the stock name "Huakang Shares" [2][3]. - As of the end of the reporting period, the total assets of the company amounted to approximately 7.56 billion yuan, reflecting an increase of 8.19% compared to the previous year [3]. - The net profit attributable to shareholders of the listed company for the reporting period was approximately 150.41 million yuan, a 2.89% increase from the previous year [3]. Financial Performance - The company's operating revenue for the reporting period reached approximately 1.87 billion yuan, representing a year-on-year growth of 37.32% [3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately 121.51 million yuan, showing a decrease of 6.56% compared to the same period last year [3]. - The net cash flow from operating activities was not specified in the provided data [3]. Shareholder Information - The total number of shareholders as of the reporting period was 17,091 [3]. - The top shareholder, Chen Deshui, holds 15.58% of the shares, while other significant shareholders include Cheng Xinping and Xu Xiaorong, each holding approximately 5.51% and 5.18% respectively [5]. Important Developments - The company anticipates revenue growth in 2025 due to the production launch of the first phase of the Zhoushan Huakang project, which involves a 1 million-ton corn deep processing health food ingredient project [5].

Group 1 - The latest stock price of Huakang Co., Ltd. is 18.05 yuan, up 0.39% from the previous trading day, with a trading volume of 24,473 hands and a transaction amount of 44 million yuan [1] - The company has a total market capitalization of 5.47 billion yuan and a price-to-earnings ratio of 16.87 times [1] - Huakang Co., Ltd. operates in the food and beverage sector, focusing on the research and production of functional sugar alcohols, starch sugars, and health food ingredients [1] Group 2 - On August 6, the company disclosed the institutional research records from July 1, with 10 institutions including Guosen Securities and Southern Fund participating, focusing on the development of the company's sugar alcohol business [1] - This marks the 95th institutional research activity for the company in the past year [1] - On August 6, the net outflow of main funds was 3.41 million yuan, with a cumulative net outflow of 10.03 million yuan over the past five trading days [1]